Buprenorphine Hydrochloride
Product Images NDC 53217-246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 53217-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine HCl Sublingual 1)

FDA Label Image

Figure (Buprenorphine HCl Sublingual 2)

FDA Label Image

Package Label (Buprenorphine HCl Sublingual 3)

Package Label (Buprenorphine HCl Sublingual 3)
This is a description of a medication called Buprenorphine HCI Sublingual. Each tablet contains 8 mg of the active ingredient Buprenorphine Hydrochloride, equivalent to Buprenorphine base. The tablet is round, white with & on one side and an MFG logo on the reverse. It is a generic for Subutex (NDC: 53217-0246-30) and should be taken every ___ hours ___ times a day. The medication is packaged by Thypha Pharma S.A. in France and the federal law prohibits dispensing without a prescription. Lot number, RX number, and INS number are also listed on the packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.